Clinical neurological phenotype of FXTAS

Maureen A. Leehey, Deborah A. Hall, Ying Liu, Randi J Hagerman

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

The classic presentation of fragile X-associated tremor/ataxia syndrome (FXTAS) is an aging man with progressive cerebellar gait ataxia, kinetic tremor, mild parkinsonism, cognitive decline, especially executive dysfunction and short-term memory deficiency, and peripheral neuropathy. Autonomic dysfunction and mood/anxiety disorders may be present. MR imaging often reveals global brain atrophy and white matter changes, including hyperintensities of the middle cerebellar peduncles, termed the “MCP sign," and of the splenium of the corpus callosum, and pathology shows intranuclear inclusions, especially in brain. Recent studies, however, have shown that the FXTAS clinical picture is variable, for example, affected persons may have minor or no tremor and others have predominant dementia or peripheral neuropathy. Onset of motor signs in men is typically in the early 60s, and approximately 40 % of carrier men and 8-16 % of carrier women over age 50 develop the disorder. Penetrance is age related, such that 75 % of men ≤ 80 years of age are affected. While less data exist regarding FXTAS in carrier women, they appear to have similar but less severe motor signs, perhaps less cognitive impairment, and some different patterns of involvement than seen in men. FXTAS, at present, is underdiagnosed largely because the presentation is often a combination of signs which are common in the elderly and because affected persons often lack insight regarding their deficits and are resistant to seeking medical care. Furthermore, the heterogeneous nature of the disorder facilitates misdiagnosis, especially in the earlier stages. Diagnosis requires FMR1 gene testing. Accurate diagnosis is not only important for the affected person but also for their family, as immediate family members may be at risk of having progeny with fragile X syndrome or other premutation associated problems.

Original languageEnglish (US)
Title of host publicationFXTAS, FXPOI, and Other Premutation Disorders
PublisherSpringer International Publishing
Pages1-24
Number of pages24
ISBN (Electronic)9783319338989
ISBN (Print)9783319338965
DOIs
StatePublished - Jan 1 2016

Fingerprint

Brain
Phenotype
Computer peripheral equipment
Pathology
Health care
Peripheral Nervous System Diseases
Tremor
Genes
Aging of materials
Imaging techniques
Data storage equipment
Kinetics
Gait Ataxia
Testing
Intranuclear Inclusion Bodies
Fragile X Syndrome
Penetrance
Corpus Callosum
Parkinsonian Disorders
Anxiety Disorders

Keywords

  • Ataxia
  • Fragile X-associated tremor/ataxia syndrome
  • Intentional tremor
  • Neuropathy
  • Parkinsonism

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)

Cite this

Leehey, M. A., Hall, D. A., Liu, Y., & Hagerman, R. J. (2016). Clinical neurological phenotype of FXTAS. In FXTAS, FXPOI, and Other Premutation Disorders (pp. 1-24). Springer International Publishing. https://doi.org/10.1007/978-3-319-33898-9_1

Clinical neurological phenotype of FXTAS. / Leehey, Maureen A.; Hall, Deborah A.; Liu, Ying; Hagerman, Randi J.

FXTAS, FXPOI, and Other Premutation Disorders. Springer International Publishing, 2016. p. 1-24.

Research output: Chapter in Book/Report/Conference proceedingChapter

Leehey, MA, Hall, DA, Liu, Y & Hagerman, RJ 2016, Clinical neurological phenotype of FXTAS. in FXTAS, FXPOI, and Other Premutation Disorders. Springer International Publishing, pp. 1-24. https://doi.org/10.1007/978-3-319-33898-9_1
Leehey MA, Hall DA, Liu Y, Hagerman RJ. Clinical neurological phenotype of FXTAS. In FXTAS, FXPOI, and Other Premutation Disorders. Springer International Publishing. 2016. p. 1-24 https://doi.org/10.1007/978-3-319-33898-9_1
Leehey, Maureen A. ; Hall, Deborah A. ; Liu, Ying ; Hagerman, Randi J. / Clinical neurological phenotype of FXTAS. FXTAS, FXPOI, and Other Premutation Disorders. Springer International Publishing, 2016. pp. 1-24
@inbook{7a63d4d2a20448b795fbbb292fafc2e6,
title = "Clinical neurological phenotype of FXTAS",
abstract = "The classic presentation of fragile X-associated tremor/ataxia syndrome (FXTAS) is an aging man with progressive cerebellar gait ataxia, kinetic tremor, mild parkinsonism, cognitive decline, especially executive dysfunction and short-term memory deficiency, and peripheral neuropathy. Autonomic dysfunction and mood/anxiety disorders may be present. MR imaging often reveals global brain atrophy and white matter changes, including hyperintensities of the middle cerebellar peduncles, termed the “MCP sign,{"} and of the splenium of the corpus callosum, and pathology shows intranuclear inclusions, especially in brain. Recent studies, however, have shown that the FXTAS clinical picture is variable, for example, affected persons may have minor or no tremor and others have predominant dementia or peripheral neuropathy. Onset of motor signs in men is typically in the early 60s, and approximately 40 {\%} of carrier men and 8-16 {\%} of carrier women over age 50 develop the disorder. Penetrance is age related, such that 75 {\%} of men ≤ 80 years of age are affected. While less data exist regarding FXTAS in carrier women, they appear to have similar but less severe motor signs, perhaps less cognitive impairment, and some different patterns of involvement than seen in men. FXTAS, at present, is underdiagnosed largely because the presentation is often a combination of signs which are common in the elderly and because affected persons often lack insight regarding their deficits and are resistant to seeking medical care. Furthermore, the heterogeneous nature of the disorder facilitates misdiagnosis, especially in the earlier stages. Diagnosis requires FMR1 gene testing. Accurate diagnosis is not only important for the affected person but also for their family, as immediate family members may be at risk of having progeny with fragile X syndrome or other premutation associated problems.",
keywords = "Ataxia, Fragile X-associated tremor/ataxia syndrome, Intentional tremor, Neuropathy, Parkinsonism",
author = "Leehey, {Maureen A.} and Hall, {Deborah A.} and Ying Liu and Hagerman, {Randi J}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-33898-9_1",
language = "English (US)",
isbn = "9783319338965",
pages = "1--24",
booktitle = "FXTAS, FXPOI, and Other Premutation Disorders",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Clinical neurological phenotype of FXTAS

AU - Leehey, Maureen A.

AU - Hall, Deborah A.

AU - Liu, Ying

AU - Hagerman, Randi J

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The classic presentation of fragile X-associated tremor/ataxia syndrome (FXTAS) is an aging man with progressive cerebellar gait ataxia, kinetic tremor, mild parkinsonism, cognitive decline, especially executive dysfunction and short-term memory deficiency, and peripheral neuropathy. Autonomic dysfunction and mood/anxiety disorders may be present. MR imaging often reveals global brain atrophy and white matter changes, including hyperintensities of the middle cerebellar peduncles, termed the “MCP sign," and of the splenium of the corpus callosum, and pathology shows intranuclear inclusions, especially in brain. Recent studies, however, have shown that the FXTAS clinical picture is variable, for example, affected persons may have minor or no tremor and others have predominant dementia or peripheral neuropathy. Onset of motor signs in men is typically in the early 60s, and approximately 40 % of carrier men and 8-16 % of carrier women over age 50 develop the disorder. Penetrance is age related, such that 75 % of men ≤ 80 years of age are affected. While less data exist regarding FXTAS in carrier women, they appear to have similar but less severe motor signs, perhaps less cognitive impairment, and some different patterns of involvement than seen in men. FXTAS, at present, is underdiagnosed largely because the presentation is often a combination of signs which are common in the elderly and because affected persons often lack insight regarding their deficits and are resistant to seeking medical care. Furthermore, the heterogeneous nature of the disorder facilitates misdiagnosis, especially in the earlier stages. Diagnosis requires FMR1 gene testing. Accurate diagnosis is not only important for the affected person but also for their family, as immediate family members may be at risk of having progeny with fragile X syndrome or other premutation associated problems.

AB - The classic presentation of fragile X-associated tremor/ataxia syndrome (FXTAS) is an aging man with progressive cerebellar gait ataxia, kinetic tremor, mild parkinsonism, cognitive decline, especially executive dysfunction and short-term memory deficiency, and peripheral neuropathy. Autonomic dysfunction and mood/anxiety disorders may be present. MR imaging often reveals global brain atrophy and white matter changes, including hyperintensities of the middle cerebellar peduncles, termed the “MCP sign," and of the splenium of the corpus callosum, and pathology shows intranuclear inclusions, especially in brain. Recent studies, however, have shown that the FXTAS clinical picture is variable, for example, affected persons may have minor or no tremor and others have predominant dementia or peripheral neuropathy. Onset of motor signs in men is typically in the early 60s, and approximately 40 % of carrier men and 8-16 % of carrier women over age 50 develop the disorder. Penetrance is age related, such that 75 % of men ≤ 80 years of age are affected. While less data exist regarding FXTAS in carrier women, they appear to have similar but less severe motor signs, perhaps less cognitive impairment, and some different patterns of involvement than seen in men. FXTAS, at present, is underdiagnosed largely because the presentation is often a combination of signs which are common in the elderly and because affected persons often lack insight regarding their deficits and are resistant to seeking medical care. Furthermore, the heterogeneous nature of the disorder facilitates misdiagnosis, especially in the earlier stages. Diagnosis requires FMR1 gene testing. Accurate diagnosis is not only important for the affected person but also for their family, as immediate family members may be at risk of having progeny with fragile X syndrome or other premutation associated problems.

KW - Ataxia

KW - Fragile X-associated tremor/ataxia syndrome

KW - Intentional tremor

KW - Neuropathy

KW - Parkinsonism

UR - http://www.scopus.com/inward/record.url?scp=85018934067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018934067&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-33898-9_1

DO - 10.1007/978-3-319-33898-9_1

M3 - Chapter

SN - 9783319338965

SP - 1

EP - 24

BT - FXTAS, FXPOI, and Other Premutation Disorders

PB - Springer International Publishing

ER -